Transport characteristics of isorhamnetin across intestinal Caco-2 cell monolayers and the effects of transporters on it

被引:38
|
作者
Duan, Jingze [1 ,2 ]
Xie, Yan [2 ]
Luo, Huilin [2 ,3 ]
Li, Guowen [4 ]
Wu, Tao [1 ]
Zhang, Tong [3 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai 201203, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Res Ctr Hlth & Nutr, Shanghai 201203, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Expt Ctr Teaching & Learning, Shanghai 201203, Peoples R China
[4] Shanghai TCM Integrated Hosp, Dept Pharm, Shanghai 200082, Peoples R China
基金
美国国家科学基金会;
关键词
Absorption mechanism; Transport; Isorhamnetin; Caco-2; cell; Transporters; RESISTANCE-ASSOCIATED PROTEIN-2; IN-VITRO; FLAVONOID QUERCETIN; P-GLYCOPROTEIN; DRUG-DELIVERY; LINE CACO-2; ABSORPTION; PERMEABILITY; EFFLUX; METABOLISM;
D O I
10.1016/j.fct.2014.02.003
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Flavonoid isorhamnetin occurs in various plants and herbs, and demonstrates various biological effects in humans. This work will clarify the isorhamnetin absorption mechanism using the Caco-2 monolayer cell model. The isorhamnetin transport characteristics at different concentrations, pHs, temperatures, tight junctions and potential transporters were systemically investigated. lsorhamnetin was poorly absorbed by both passive diffusion and active transport mechanisms. Both trans- and paracellular pathways were involved during isorhamnetin transport. Active transport under an ATP-dependent transport mechanism was mediated by the organic anion transporting peptide (OATP); isorhamnetin's permeability from the apical to the basolateral side significantly decreased after estrone-3-sulfate was added (p < 0.01). Efflux transporters, P-glycoproteins (P-gp), breast cancer resistance proteins (BCRP) and multidrug resistance proteins (MRPs) participated in the isorhamnetin transport process. Among them, the MRPs (especially MRP2) were the main efflux transporters for isorhamnetin; transport from the apical to the basolateral side increased 10.8-fold after adding an MRP inhibitor (MK571). This study details isorhamnetin's cellular transport and elaborates isorhamnetin's absorption mechanisms to provide a foundation for further studies. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [21] Transport of thalidomide by the human intestinal Caco-2 monolayers
    Shufeng Zhou
    Yan Li
    Phillip Kestell
    Peter Schafer
    Eli Chan
    James W. Paxton
    European Journal of Drug Metabolism and Pharmacokinetics, 2005, 30 : 49 - 61
  • [22] Transport of thalidomide by the human intestinal Caco-2 monolayers
    Zhou, SF
    Li, Y
    Kestell, P
    Schafer, P
    Chan, E
    Paxton, JW
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2005, 30 (1-2) : 49 - 61
  • [23] Transport of harman alkaloids across Caco-2 cell monolayers
    Khan, SI
    Abourashed, EA
    Khan, IA
    Walker, LA
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (04) : 394 - 397
  • [24] Transepithelial transport of flavanone in intestinal Caco-2 cell monolayers
    Kobayashi, Shoko
    Konishi, Yutaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 368 (01) : 23 - 29
  • [25] Transport evaluation of alendronate across Caco-2 cell monolayers
    Karamustafa, F.
    Celebi, N.
    Degim, Z.
    Unal, N.
    PHARMAZIE, 2009, 64 (02): : 98 - 103
  • [26] CriticalSorb™ Promotes Permeation of Flux Markers Across Isolated Rat Intestinal Mucosae and Caco-2 Monolayers
    Brayden, D. J.
    Bzik, V. A.
    Lewis, A. L.
    Illum, L.
    PHARMACEUTICAL RESEARCH, 2012, 29 (09) : 2543 - 2554
  • [27] Transport of Proteolytic Enzymes Across Caco-2 Cell Monolayers
    Udo Bock
    Corinna Kolac
    Gerrit Borchard
    Kerstin Koch
    Roland Fuchs
    Peter Streichhan
    Claus-Michael Lehr
    Pharmaceutical Research, 1998, 15 : 1393 - 1400
  • [28] Transport of proteolytic enzymes across Caco-2 cell monolayers
    Bock, U
    Kolac, C
    Borchard, G
    Koch, K
    Fuchs, R
    Streichhan, P
    Lehr, CM
    PHARMACEUTICAL RESEARCH, 1998, 15 (09) : 1393 - 1400
  • [29] Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers
    Guan, Min
    Zhu, Qiao-Ling
    Liu, Yang
    Bei, Yong-Yan
    Gu, Zong-Lin
    Zhang, Xue-Nong
    Zhang, Qiang
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 1921 - 1930
  • [30] Comparison of bidirectional cephalexin transport across MDCK and Caco-2 cell monolayers: Interactions with peptide transporters
    Putnam, WS
    Pan, L
    Tsutsui, K
    Takahashi, L
    Benet, LZ
    PHARMACEUTICAL RESEARCH, 2002, 19 (01) : 27 - 33